Point72 Asset Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-16,200
Closed -$1.09M – 4005
2025
Q3
$1.09M Buy
16,200
+1,100
+7% +$73K ﹤0.01% 1670
2025
Q2
$984K Buy
+15,100
New +$905K ﹤0.01% 1564
2023
Q1
– Sell
-6,700
Closed -$501K – 2370
2022
Q4
$501K Hold
6,700
– – ﹤0.01% 1150
2022
Q3
$432K Hold
6,700
– – ﹤0.01% 1189
2022
Q2
$464K Buy
+6,700
New +$497K ﹤0.01% 1201
2018
Q3
– Sell
-300,000
Closed -$11.9M – 1087
2018
Q2
$11.9M Buy
+300,000
New +$11.5M 0.05% 403
2016
Q3
– Sell
-55,500
Closed -$1.92M – 774
2016
Q2
$1.92M Buy
+55,500
New +$1.92M 0.01% 571

Other funds holding HOLX

Point72 Asset Management's HOLX Position: Q2 2026 in Review

Point72 Asset Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 71,776 shares — an estimated $5.43M sold.

Point72 Asset Management first reported a position in HOLX in Q3 2015 and held it in 28 quarters. The position peaked at $132M in Q3 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Point72 Asset Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Point72 Asset Management sold 71,776 Hologic shares in Q2 2026, an estimated $5.43M.
  • Point72 Asset Management first reported a position in Hologic in Q3 2015 and held it in 28 quarters.
  • Point72 Asset Management's Hologic position peaked at $132M in Q3 2023.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.